仙鹿活骨丸的研制及其治疗股骨头坏死的机制研究
|
摘要
[工作目的]
研制一种创新型治疗股骨头坏死(Avascular Necrisis of the Femoral Head, ANFH)的新药-仙鹿活骨丸,并从细胞学角度探索其治疗股骨头坏死的机制。
[研究方法]
在本研究中,我们在临床经验方的基础上制成了治疗股骨头坏死的有效方剂-仙鹿活骨丸,其处方提出了益肾健骨、活血化瘀、通经活络止痛治疗股骨头坏死的新思路及重用动物类药的用药方法。处方将虫类药制成破壁微粉,植物药进行有效成分提取成浓缩剂,混合制成水丸。使用维甲酸型和激素型大鼠股骨头坏死两种最新的动物模型,从细胞水平上对仙鹿活骨丸激活成骨细胞功能、减少成骨细胞凋亡机制进行探讨。
[研究结果]
仙鹿活骨丸可以有效改善维甲酸所致股骨头缺血后骨密度降低,增强股骨头和股骨窝部位的骨密度水平,在微观的组织学方面,能够改善软骨表面凹陷,降低骨细胞变性坏死度;仙鹿活骨丸还可明显改善注射醋酸强的松龙后股骨头坏死大鼠体重下降等症状,改善血流变指标,增加HOM /HOP比值,流氏细胞仪检测和电镜观察表明其可以有效改善激素引起的骨细胞坏死。对大鼠成骨细胞(OB)进行分离和培养,MTT比色实验表明仙鹿活骨丸可以提高OB的增值能力,增强ALP表达,促进OB由G0/G1期进入S期,促进OB有丝分裂,促进成骨细胞再生。基因检测提示仙鹿活骨丸可以抑制OB凋亡过程中Bcl-2表达的下降及Bax表达的上升,从而抑制OB凋亡,阻止股骨头坏死恶化。急性毒性和长期毒性实验结果表明仙鹿活骨丸低毒、安全,可以在临床上使用。
[研究结论]
仙鹿活骨丸作为一种新药,成本低、副作用小、能够长期服用。其制备工艺先进,对激素型和维甲酸型大鼠股骨头坏死有较好治疗作用,还可以有效保护成骨细胞功能,治疗股骨头坏死,值得推广和应用。
[PURPOSE] To develope a new creative drug to treat ANFH (Avascular Necrisis of the Femoral Head) named Xianlu Huogu Wan, and to study the treatment mechanism of Xianlu Huogu Wan on ANFH.
[METHOD] In this study, we made a curative prescription of ANFH named Xianlu Huogu Wan. The prescription has some innovations on treatment of ANFH by tonifying kidney and healthy bone, promoting blood to dissolve the stasis, promotion and activating collaterals to relieve pain. We broke the insects drugs to worm powder drugs, extracted herbal for the active ingredients to concentrated dose and mix into water-paste pill. we used two types of animal model in rats, retinoic acid-caused and corticosteroid-caused type, and studied the activate function on osteoblast and reduction of osteoblast apoptosis on the cellular level.
[RESULT] Xianlu Huogu Wan can improve reduction of the bone mineral density effectively after the lack of blood of femoral head due to retinoic acid induced and enhance the level of bone mineral density of the femoral head and femoral fossa. It can improve the cartilage surface of depression and reduce the degrees of cell degeneration and necrosis of cartilage. It can improve symptoms significantly, such as weight loss of the ANFH rats injected prednisolone acetate, improve blood flow targets, increase the HOM/HOP ratio and improve the bone necrosis caused by hormone by cell flow cytometry and electron microscopy. We isolate and culture the rat osteoblasts (OB), MTT colorimetric cents experiments show that it can increase the generation capabilities of OB and enhanced ALP expression, it can promote OB from G0/G1 phase to S phase, thus contributing to OB mitosis to promote osteoblast proliferation. Genetic tests show that Xianlu Huogu Wan can inhibit the decreased expression of Bcl-2 and increase expression of Bax in the process of OB apoptosis, thereby inhibit the OB necrosis to treat ANFH. The acute toxicity and long-term toxicity test results show that it has low toxicity to be used in clinical practice.
[CONCLUSION] As a new medicine of low cost and low side effect, Xianlu Huogu Wan can be used to treat ANFH for long-term. Due to the advanced preparation, good therapeutic effect on hormone-caused and retinoic acid-caused ANFH on rat and the effective protection of osteoblast function in treatment of ANFH, it is worthy to popularize and apply.
研制一种创新型治疗股骨头坏死(Avascular Necrisis of the Femoral Head, ANFH)的新药-仙鹿活骨丸,并从细胞学角度探索其治疗股骨头坏死的机制。
[研究方法]
在本研究中,我们在临床经验方的基础上制成了治疗股骨头坏死的有效方剂-仙鹿活骨丸,其处方提出了益肾健骨、活血化瘀、通经活络止痛治疗股骨头坏死的新思路及重用动物类药的用药方法。处方将虫类药制成破壁微粉,植物药进行有效成分提取成浓缩剂,混合制成水丸。使用维甲酸型和激素型大鼠股骨头坏死两种最新的动物模型,从细胞水平上对仙鹿活骨丸激活成骨细胞功能、减少成骨细胞凋亡机制进行探讨。
[研究结果]
仙鹿活骨丸可以有效改善维甲酸所致股骨头缺血后骨密度降低,增强股骨头和股骨窝部位的骨密度水平,在微观的组织学方面,能够改善软骨表面凹陷,降低骨细胞变性坏死度;仙鹿活骨丸还可明显改善注射醋酸强的松龙后股骨头坏死大鼠体重下降等症状,改善血流变指标,增加HOM /HOP比值,流氏细胞仪检测和电镜观察表明其可以有效改善激素引起的骨细胞坏死。对大鼠成骨细胞(OB)进行分离和培养,MTT比色实验表明仙鹿活骨丸可以提高OB的增值能力,增强ALP表达,促进OB由G0/G1期进入S期,促进OB有丝分裂,促进成骨细胞再生。基因检测提示仙鹿活骨丸可以抑制OB凋亡过程中Bcl-2表达的下降及Bax表达的上升,从而抑制OB凋亡,阻止股骨头坏死恶化。急性毒性和长期毒性实验结果表明仙鹿活骨丸低毒、安全,可以在临床上使用。
[研究结论]
仙鹿活骨丸作为一种新药,成本低、副作用小、能够长期服用。其制备工艺先进,对激素型和维甲酸型大鼠股骨头坏死有较好治疗作用,还可以有效保护成骨细胞功能,治疗股骨头坏死,值得推广和应用。
[PURPOSE] To develope a new creative drug to treat ANFH (Avascular Necrisis of the Femoral Head) named Xianlu Huogu Wan, and to study the treatment mechanism of Xianlu Huogu Wan on ANFH.
[METHOD] In this study, we made a curative prescription of ANFH named Xianlu Huogu Wan. The prescription has some innovations on treatment of ANFH by tonifying kidney and healthy bone, promoting blood to dissolve the stasis, promotion and activating collaterals to relieve pain. We broke the insects drugs to worm powder drugs, extracted herbal for the active ingredients to concentrated dose and mix into water-paste pill. we used two types of animal model in rats, retinoic acid-caused and corticosteroid-caused type, and studied the activate function on osteoblast and reduction of osteoblast apoptosis on the cellular level.
[RESULT] Xianlu Huogu Wan can improve reduction of the bone mineral density effectively after the lack of blood of femoral head due to retinoic acid induced and enhance the level of bone mineral density of the femoral head and femoral fossa. It can improve the cartilage surface of depression and reduce the degrees of cell degeneration and necrosis of cartilage. It can improve symptoms significantly, such as weight loss of the ANFH rats injected prednisolone acetate, improve blood flow targets, increase the HOM/HOP ratio and improve the bone necrosis caused by hormone by cell flow cytometry and electron microscopy. We isolate and culture the rat osteoblasts (OB), MTT colorimetric cents experiments show that it can increase the generation capabilities of OB and enhanced ALP expression, it can promote OB from G0/G1 phase to S phase, thus contributing to OB mitosis to promote osteoblast proliferation. Genetic tests show that Xianlu Huogu Wan can inhibit the decreased expression of Bcl-2 and increase expression of Bax in the process of OB apoptosis, thereby inhibit the OB necrosis to treat ANFH. The acute toxicity and long-term toxicity test results show that it has low toxicity to be used in clinical practice.
[CONCLUSION] As a new medicine of low cost and low side effect, Xianlu Huogu Wan can be used to treat ANFH for long-term. Due to the advanced preparation, good therapeutic effect on hormone-caused and retinoic acid-caused ANFH on rat and the effective protection of osteoblast function in treatment of ANFH, it is worthy to popularize and apply.
引文
[1]袁俊英,孙强三,成人缺血性股骨头坏死的治疗进展,现代中西医结合杂志, 2007,16(8):147～1149
[2]种清治,成人股骨头缺血性坏死的诊断和治疗综述,现代中医药,1994,5(6):4～7
[3]赵德伟,田丰德,感染后并发股骨头坏死的病因及治疗,中国骨与关节损伤杂志,2007,22(4):283～285
[4] Uno K, Kawai K, Hirohata K, et al, Steroid in-duced early changes of the femoral head in man-histological study of autopsied cases.Ryu-machi, 1991,31,282～289
[5]王峰,非创伤性股骨头缺血性坏死病因及发病机理研究进展,实用诊断与治疗杂志,2007,21(2):121～123
[6]汪晓燕,陈卫衡,宋剑南等,非创伤性股骨头坏死及其证候与血脂代谢的关系,中国中医基础医学杂志,2007,13(5):368～369
[7]董天华,成人股骨头缺血性坏死的现代新概念,苏州医学院学报,2000,20 (12):1079～1081
[8]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,105～109
[9]赵德伟,股骨头缺血性坏死修复与重建的意义,中华显微外科杂志,2006, 29(3):165～166
[10]李宝新,李玉坤,Wnt调节通路对骨调节研究新进展,国际骨科学杂志,2008,29 (3):179～181.
[11]柳海华,彭磊,孙殿敬,不同药物配伍方案在介入治疗早期股骨头缺血坏死中的疗效差别,实用医技杂志,2007,21 (14):2815～2817
[12]曹春林,施顺清,中药药剂学,上海:科学技术出版社,1984,248～249
[13]张洪泉,余永新,中华抗衰老医药学,北京:科学技术出版社,2000,5161
[14]涂扬茂,张朝驹,活骨丸对股骨头缺血性坏死患者的血脂和血液流变学影响,中医药临床杂志,2007,19(2):163～164
[15] Yang, H.O., Park, Stimulatory effects of monoacetyldiglycerides on hematopoie -sis, Biol Pharm Bull 27, 2004, 1121-1125.
[16]郇宜俊,骨新生胶囊治疗股骨头坏死的药效学研究,山东中医杂志,2007,26(7):480～482
[17] Yang, H.O., Kim, S.H., Cho,et al, Purification and structural determination of hematopoietic stem cell-stimulating monoacetyldiglycerides from Cervus nippon (deer antler), Chemical and Pharmaceutical Bulletin 52, 2004, 874–878.
[18]张弛,杨志伟,朱明双,等,活血通络法对激素性股骨头坏死家兔模型的组织形态学影响,新疆医科大学学报,2007,30(5):452～454
[19]高彦辉,付松波,孙辉,等,氟中毒大鼠骨组织病理改变动态分析,中国地方病学杂志,2007,26(1):18～21
[20]郇宜俊,骨新生胶囊治疗股骨头坏死的药效学研究,山东中医杂志,2007,26(7):480～482
[21]张弛,何洪阳,杨志伟,等,活血通络法防治激素性股骨头坏死的作用及机制研究,成都中医药大学学报,2007,30(1):39～43
[22]李鸿,贾丙申,激素合并内毒素诱导大鼠股骨头坏死扫描电镜观察,中国比较医学杂志,2007, 17(5):256～258
[23]何齐芳,尚希福,茶黄素抑制激素性股骨头坏死的实验研究,安徽医科大学学报,2007,42(4):415～419
[24]程少容,王仁法,高小玲,等,动态增强MRI评价股骨头血流灌注状态的实验研究,中国临床医学影像杂志,2007,18 (2):110～114
[25]李楠,王和鸣,郭素华,等,巴戟天多糖含药血清对体外培养成骨细胞凋亡的保护作用观察,中国骨伤,2008,21 (1): 39～41
[26]许书亮,洪加源,复元散对激素性股骨头坏死生化代谢影响的实验研究,中国中医骨伤科杂志,1998,6 (6):8～12
[27]金掌,王维佳,王喜波,等,二仙益骨汤对实验性兔股骨头缺血性坏死骨小梁、骨血管面积及矿化等指标的影响,中医正骨,2008,20 (1):3～5
[28] Neuman R.E., Logan M.A., The determination of hydroxyproline. J Biol Chem 184, 1950, 299–306.
[29]熊明月,王坤正,党晓谦,早期激素性股骨头坏死骨细胞凋亡的实验研究,中国修复重建外科杂志,2007,21(3):262～265
[30] Wang Z., Peng H., Li Z.H.,et al, Effect of Cervus and Cucumis Polypeptide Injection on the Rabbits’Radius Fracture and Expression of Vascular Endothelial Growth Factor, Medical Journal of Wuhan University 28, 2007, 193-199.
[31]林永城,曾炎辉,张泽玫,补肾复活汤对中老年股骨头缺血性坏死患者血液流变学的影响,中国康复,2007,22(1):9～10
[32] Meunier P I, Bone histomorphometry in corticosteroid-induced osteo-porosis and cushings syndronce, Advan Exp Med Bio, 1989, 171～191
[33]齐振熙,曹阳,不同治法防治激素性股骨头缺血性坏死的实验研究,中国骨伤,2002,15(2):77～78
[34]章建华,宋登峰,成立,等,骨健制剂对激素性股骨头坏死血液流变学的影响,中医正骨,2008,20(4):13～14
[35]李孝林,杜亚明,张朝驹,等,活骨丸对激素性股骨头缺血坏死家兔血脂及血液流变学的影响,光明中医,2006,21(9):58～59
[36]汪喆，彭昊，李章华，等，鹿瓜多肽注射液对骨折愈合的作用及对血管内皮生长因子表达的影响,武汉大学学报(医学版) ,2007,28(2):196～204
[37]李小宏,李盛华,叶丙霖,激素性股骨头缺血性坏死模型诱导与中药治疗的实验研究进展,甘肃中医,2007,20 (11):58～59
[38]李盛华,姚正凯,激素性股骨头坏死细胞凋亡的实验研究进展,甘肃中医,2007,20(9):61～62
[39]张弛,何洪阳,杨志伟,等,活血通络法防治激素性股骨头坏死的作用及机制研究,成都中医药大学学报,2007,30(1):39～43
[40]闫燃,张雪哲,皮质类固醇致股骨头缺血性坏死的磁共振成像早期改变的实验研究,中日友好医院学报,2007,21(1):28～33
[41]吴云刚,肖鲁伟,童培建,右归饮对激素性股骨头坏死患者股骨近端骨髓骨活性影响的实验研究,中国骨伤,2009,22(2):115～117
[42]何正华,王林,余鹏,不同组织源性细胞作为大动物骨缺损修复研究用骨组织工程种子细胞的增殖及成骨分化比较,武警医学院学报,2008,17 (2) :109～113.
[43]李蔚,孙宜萍,朱国英,雌激素在体外对大鼠成骨细胞的作用,中国组织工程研究与临床康复,2008,12 (11):2061～2064
[44]刘日光,沈冯君,丹仙康骨胶囊对培养成骨细胞影响的观察,中国骨伤,2004,17 (2):77～79
[45]杨亚军,朱庆生,CDMP1诱导大鼠脂肪干细胞体外成软骨细胞的实验研究,第四军医大学学报,2008,29(4):342～345
[46]吴惠明,王维佳,王喜波,等,BMP加丹参治疗股骨头坏死实验研究,中国中医骨伤科杂志,2008, 16 (2):36～39
[47]周小莉,李荣亨,.复元胶囊对软骨细胞凋亡细胞外信号调节蛋白激酶1/2信号通路的作用研究,中国老年学杂志,2008,28(4):329～331
[48]齐振熙,曹阳,不同治法对激素性股骨头坏死生化代谢影响的实验研究,中国中医药信息杂志,2001,8 (12):39～40
[49] Kim S.K, Lee M.H., Rhee, et al, Studies on the effects of biomedicinal agents on serum concentration of Ca2+, P and ALP activity in osteoporosis-induced rats, Journal of Veterinary Science 4, 2003,151–154.
[50]朱文菁,MTT法分析培养成骨细胞的存活和增殖能力,上海医科大学学报,1995,22(4):254～257
[51]中药新药研究指南,北京:中国卫生部药政管理局, 1993,203～207.
[52]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,17～19
[53]赵德伟,田丰德,单纯髋臼前后缘发育不良的解剖学与临床研究,中国临床解剖学杂志,2008,26(1):101～104
[54] Mont M.A,Hungerford D.S,Non-traumatic avascular necrosis of the femoral head,J Bone Joint Surg Am 77, 1995,459-474
[55]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,207
[56]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,235
[57]史永惠,赵熙,左敬全,成人早期股骨头缺血性坏死的影像学诊断价值,实用放射学杂志,2007,23(8):1080～1082
[58]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,169～171
[59]杨党牢,李州利,石炳毅,等,肾移植术后股骨头坏死两例报告并文献复习,现代外科,1999,5(1):46～48
[60]王雨,王爱民,沈岳,等,带旋髂深血管髂骨瓣与人工髋关节置换联合Ⅰ期治疗双侧股骨头无菌性坏死,创伤外科杂志,2007,9(3):222～224
[61]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,134～197
[62]易正湘,龚长虹,成人股骨头缺血坏死的病理及X线、CT、MRI诊断,医学临床研究,2008,25(1):164～166
[63]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,67～85
[64] Vail T.P., Covington D.B., The incidence of osteonecrosis, In: Urbaniak JR, Jones JR, eds. Osteonecrosis: Etiology, Diagnosis, Treatment. Rosemont, Ill: American Academy of Orthopedic Surgeons,1997, 43-49.
[65] Compston, J., Glucocorticoid-induced osteoporosis, Horm Res 60, 2003,77～79
[66]马强,马大庆,靳二虎,等,激素致骨缺血坏死动物模型的影像学初步研究,山西医药杂志,2007,36(4):298～230
[67]胡长根,陈君长,贺西京,等,激素性股骨头坏死与血液流变学变化的关系,西安交通大学学报(医学版) ,2003,24(6):595～598
[68]刘平,刘永平,杜娈英,等,激素性股骨头缺血坏死的发病机理,承德医学院学报,1998,15(3):238～239
[69]程少丹,李武军,杨豪,等,激素性股骨头坏死发病机制研究进展,中医正骨,2002,14(7):51～53
[70]张华峰,马信龙,激素性股骨头坏死的骨质疏松学说,中国骨质疏松杂志,2007,13(2):130～133
[71] Kim K.H., Kim K.S., Choi B.J., et al, Anti-bone resorption activity of deer antler aquaacupunture, Journal of Ethnopharmacology 96, 2005, 497～506
[72] Mok C.C., Lau C.S.,Wong R.W.S., Risk factors for avascular bone necrosis in systemic lupus erythematosus, Br J Rheumatol 37, 1998, 895～900
[73] Mont M.A., Glueck C.J., Pacheco I.H., et al, Risk factors for osteonecrosis in systemic lupus erythematosus, J Rheumatol 24, 1997, 654～662
[74]周正新,袁浩,论治股骨头缺血性坏死的学术特点,中医正骨,2003, 15(6):56～57
[75]林乔龄,李民,儿童股骨头缺血坏死病理机制研究进展,福建中医药, 2000,31(5):41～42
[76]刘艺,张春明,修英霞,等,股骨头坏死患者血液流变学指标的初步观察,微循环学杂志,1997,7(4):27～28
[77]张年春,曾维权,何作云,股骨头坏死的血液流变学临床研究,中国血液流变学杂志,1999,9(4)::227～238
[78]何伟,徐传毅,方斌,等,非创伤性股骨头坏死血液流变学改变及意义,中国中医骨伤科杂志,2001,9(6):24～26
[79]匿名,股骨头坏死的发病原因,求医问药,2004,12:7
[80]崔操,喻爱喜,常巍,等,高压氧对兔激素性股骨头坏死的血液流变学影响,郧阳医学院学报,2006,25(4):214～217
[81]骆生法,激素性股骨头坏死的血液流变学改变,浙江中西医结合杂志,2003,13(8):473～474
[82]崔操,常巍,喻爱喜,高压氧治疗激素性股骨头坏死的血液流变学改变与意义,武汉大学学报(医学版) ,2007,28(1):103～123
[83]俞索静,吴承亮,非创伤性股骨头坏死的病理组织学探讨,中医正骨,2007, 19(8):83～85
[84]赵伦华,朱大和,程少华,高压氧治疗激素诱导兔股骨头缺血性坏死的病理观察,临床与实验病理学杂志,2006,22(1) :78～80
[85]罗杨,刘一,张科强,MAPK信号传导通路在间充质干细胞向成骨细胞分化中的作用,吉林医学,2008,29(6):443～445
[86]宋大勇,赵宝权,刘兴汉,等,重组成骨生长肽对兔同种异体骨移植的成骨影响,哈尔滨医科大学学报,2003,37(6):474～476
[87]唐林,邵玶,林珠,等,不同大小机械牵张力对成骨细胞MMP-13/TIMP-1表达的影响,临床口腔医学杂志,2008, 24 (3):133～136
[88]张永乐,王义生,窦东梅,单纯激素性股骨头坏死发病机制的研究,实用全科医学,2007,5 (8):661～662
[89]崔永锋,肖鲁伟,童培健,硬化带导致股骨头坏死修复过程中断与资源竞争假说,中华中医药学刊,2009,27(1):71～73
[90]秦泗通,蒋青,黄际河,等,p38丝裂原活化蛋白激酶抑制剂对大鼠骨关节炎软骨细胞凋亡的影响,山东医药,,2008, 48 (6):6～8
[91] Kelly P, Montgomery R.J., Bronk J.T. , Reaction of the circulatory system to injury and regeneration, Clin Orthop,1990, 254,275-288.
[92]顾九君,刘兴炎,盛俊东,等,缺氧对大鼠成骨细胞增殖及凋亡的影响,临床军医杂志,2007,35(2):171～173
[93]胡柏松,童培建,激素性股骨头坏死骨重建失衡的实验研究进展,云南中医中药杂志, 2007,28(8):38～40
[94] Mont M.A., Jones L.C., Osteonecrosis of the femoral head Potential treatment with growth and differentiation factors, ClinOthop,1998,314～315
[95]张大学,王丹,生长分化因子治疗股骨头坏死,医学综述,2001,7(9) :517～519
[96]王琪,荀三怀,血管源性生长因子在骨折愈合中的作用,国外医学·骨科学分册,2003,24(4):207～209
[97] Feng J.Q., Chen D., Ghosh-Choudhury, et al, Bone morphogenetic protein 2 transcripts in rapidly developing deer antler tissue contain an extended 5' non-coding region arising from a distal promoter, Biochimica et Biophysica Acta 1350, 1997,47～52
[98]樊粤光,徐传毅,何伟,等,激素性股骨头坏死病程中股骨头局部VEGF mRNA表达的变化及意义,中国矫形外科杂志,2002,10(8):784～786
[99]王正东,柏树令,范军,等, 1,25二羟基胆钙化醇诱导大鼠骨髓单核细胞向破骨细胞转化的机制,解剖学杂志,2008,31(2):148～150
[100]张希中,王清华,王红坡,股骨头缺血坏死的CT早期诊断及分期,新乡医学院学报,2001,18(4):294～295
[101]陈明,郑琼,方真华,阿伦膦酸钠对骨髓生成破骨细胞及骨吸收作用的影响,中国矫形外科杂志, 2008,16 (4):282～284
[102]倪建平,施杞,非创伤性股骨头缺血性坏死的病因研究进展,山东医药,2008,48(6):113～114
[103]郭辉,刘奕琛,葛根素对大鼠成骨细胞代谢调控机制的实验研究,现代中医药,2008,28 (1):48～50
[104] Calder J D, Buttery L,Revell P A,et al, Apoptosis-asignificant cause of bone cell death in osteonecrosis of the femoral head, J Bone JointSurg(Br), 2004, 86(8): 1209-1213.
[105] Eberhardt A W, Yeager-Jones A, Blair H C., Regiona trabecular bone matrix degeneration and osteocyt death in femora of glucocorticoid-treated rabbits, Endocrinology, 2001, 142(3): 1333-1340.
[106] Weinstein R.S., Nicholas R.W., Manolagas S.C., Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip, J Clin Endocrinol Metab, 2000, 85(8): 2907-2912.
[107]齐振熙,陈磊,活血化瘀法对激素性股骨头缺血坏死血液流变学的影响,福建中医学院学报,2006,16 (6):22～24
[108]季爱玉,于腾波,袁万青,等,体内转染Ad/CMV-Htgf-?1对兔椎间盘髓核细胞凋亡及Bcl-2及Bax表达的影响,山东医药,2008,48(17):36～
[109]王建敏,莫耘松,张桂珍,胃黏膜病变组织PNCA、Bcl-2和Bax的表达及意义,实用中西医结合临床,2006,6(5):4～6
[110]刘列,王胜波,赵花,等,颈椎间盘退变过程中细胞凋亡与Bax,Caspase23的表达,第四军医大学学报,2008,29(13):1191～1194
[111]陈德权,邓树勋,彭峰林,间歇运动对大鼠骨骼肌凋亡基因Bax、Bcl-2及相关因素的影响,北京体育大学学报,2008,31(7):922～925
[112]彭程,肖涛,罗远明,等, IGF-1对IL-1诱导的兔关节软骨细胞NO和PGE的影响,中南大学学报(医学版),2008,33(3):197～203
[113]张自强,赵东旭,杨新林,羟脯氨酸的研究与开发,氨基酸和生物资源, 2006,28(1):55～58
[114]吴铁,刘钰瑜,崔燎,等,不同剂量的环磷酰胺对大鼠骨药理作用探讨,中国药理学通报,2001,17(3):329～33
[115] Pedrini Mile A, Chemical study on the ground substance of human epiphy seal plate cartilage, J Bone Joint Surg (Am), 1967 ,49: 1628
[116] Blumenkrantz N.,Asboe-Hansen E., An assay for total hexosamine and a differential assay for glucosamine and galactosamine, Clin Biochem 9, 1976, 269～274
[117]石峰,刘卫东,吉士俊,等,胚胎期及新生儿股骨头骨骺中氨基多糖及钙的含量,中国医科大学学报,1998,27(4):401～403
[118]李刚,通络生骨胶囊治疗激素性股骨头坏死临床与相关实验研究:[博士论文],广州;广州中医药大学,1997
[119]汪喆，彭昊，李章华，等，鹿瓜多肽注射液对骨折愈合的作用及对血管内皮生长因子表达的影响,武汉大学学报(医学版),2007,28(2):196～204
[120]赵玉岩,郭磊,田蕾,等,骨性关节炎软骨细胞中胰岛素样生长因子表达的研究,中国老年学杂志,2009,29(2):195～187
[121]李建华,黄建荣,张雅洁,等,胰岛素样生长因子-1对软骨细胞凋亡的抑制,中国临床康复,2003,23(7):315
[122] Frisbie D D,Sandler E A,Trotter G W, et al. Metablolic and mitogentic activities of insulim-like growth factor-1 in interleukin-1-conditioned equine cartilage,Am J Vet Res,2000,61(4):436～441
[123] Im H J,Pracione C,Chubinskaya S,et al,Inhibitiory effects of insulin-like growth factor-1 angosteogeneic protain-1 on fibronectin fragment-and interleukin -1 beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes,J Biol Chem,2003,278(28):25386-25394
[124] Wang J, Elewaut D, Veys E M, et al,Insulin-like growth factor 1-included interleukin-1 receptorⅡoverrides the activity of interleukin-1 and controls the homecostasis of the extra-cellular matrix of caitilage,Arthritis Rheum,2003, 48(5): 1281-1291.
[125] Makower A M, Skotter A,Wroblewski J,Binding of insulin-like growth factor- 1(TGF-1) to primary cultures of chondrocytes from rats rib growth cartilage,Cell Biol Int Rep,1989,13(5):655-665.
[126]张绍昆,刘一,吴宏,等,外源性人胰岛素样生长因子-1基因在关节软骨细胞中的表达,中华实验外科杂志,2005,3(22):278～280
[127] Hyun H.J.,Chan H.K., Jong H. C.,et al, Bilateral anterior cingulotomy for refractory obsessive-compulsive disorder:Long-term follow-up results, Chin J Nerv Ment Dis, 2006, 32 (5):392-398.
[128]文良元,黄公怡,路奎元,等,激素型股骨头坏死的发病机制研究,中华外科杂志,1998,36 (1):39～41
[129]郭磊,赵玉岩,张世亮,等,维甲酸调控IGF-2基因对软骨细胞促凋亡的作用,中国修复重建外科杂志,2008,22 (2):217～220
[130]郭磊,赵彦艳,董凌月,等,二恶英对成骨细胞胰岛素样生长因子家族基因表达的抗雌激素作用,中华医学遗传学杂志, 2003, 20(6):490～494
[131] Chang C C, Osteo-necrosis current perr-spectives on pathogenesis and treatment, Semin Arthritis- Rheum,1993,23(1):47
[132]赵金东,吕松岑,薛震,等,激素性股骨头坏死动物模型的建立与评价,中国骨肿瘤骨病,2007,6(4):220～225
[133]宋渊,李盛华,股骨头缺血性坏死动物模型研究进展,甘肃中医,2006, 19(5):43～45
[134]田琨,童培建,肖鲁伟,激素性股骨头缺血性坏死动物模型研究进展,江西中医学院学报,2007,19(1):95～97
[135]周强,李起鸿,柳风轩,持续大剂量地塞米松诱导兔股骨头坏死的实验研究,西藏医药杂志,1999,20(3):19
[136]Yamat nat oT, Corticosteroid enhances the exprimental in-duction of osteonecerosis on rabbits with shwartzman reaction, Clin Orthop,1995,316.
[137] Mastuim saito S,Ohzono K, Experimental steroid in duced ostenecrosis inadult rabbits withhypersensitivity was colitis, Clin Orthop, 1992, 61.
[138]周景华,王立春,活骨汤治疗股骨头缺血性坏死的实验研究,中医研究,2000,16(1):45
[139]郭坤亮,安洪,蒋电明,酒精性股骨头缺血性坏死动物模型的建立与探讨,贵州医药,2002,26(10):882～884
[140]杨述华,杨操,许伟华,等,液氮冷冻建立兔股骨头缺血性坏死模型,中华矫形外科杂志,2001,8(1):48
[141]王江泳,王保芝,崔慧先,改良液氮冷冻法制备家兔股骨头坏死模型的形态学研究,河北医科大学学报,2008, 29(1):5～8
[142]王胜军,赵文海,液氮冷冻建立兔股骨头缺血性坏死模型,长春中医药大学学报,2008,24(4):402～403
[143]陈凯,蔡郑东,多孔担金属植人治疗早期股骨头坏死研究进展,国际骨科学杂志,2008, 29(1):41～42
[144]黄昌林,高旺,黄涛,中药对非创伤性股骨头坏死分期治疗作用的临床观察,解放军医学杂志,2009, 34(5):504～505
[2]种清治,成人股骨头缺血性坏死的诊断和治疗综述,现代中医药,1994,5(6):4～7
[3]赵德伟,田丰德,感染后并发股骨头坏死的病因及治疗,中国骨与关节损伤杂志,2007,22(4):283～285
[4] Uno K, Kawai K, Hirohata K, et al, Steroid in-duced early changes of the femoral head in man-histological study of autopsied cases.Ryu-machi, 1991,31,282～289
[5]王峰,非创伤性股骨头缺血性坏死病因及发病机理研究进展,实用诊断与治疗杂志,2007,21(2):121～123
[6]汪晓燕,陈卫衡,宋剑南等,非创伤性股骨头坏死及其证候与血脂代谢的关系,中国中医基础医学杂志,2007,13(5):368～369
[7]董天华,成人股骨头缺血性坏死的现代新概念,苏州医学院学报,2000,20 (12):1079～1081
[8]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,105～109
[9]赵德伟,股骨头缺血性坏死修复与重建的意义,中华显微外科杂志,2006, 29(3):165～166
[10]李宝新,李玉坤,Wnt调节通路对骨调节研究新进展,国际骨科学杂志,2008,29 (3):179～181.
[11]柳海华,彭磊,孙殿敬,不同药物配伍方案在介入治疗早期股骨头缺血坏死中的疗效差别,实用医技杂志,2007,21 (14):2815～2817
[12]曹春林,施顺清,中药药剂学,上海:科学技术出版社,1984,248～249
[13]张洪泉,余永新,中华抗衰老医药学,北京:科学技术出版社,2000,5161
[14]涂扬茂,张朝驹,活骨丸对股骨头缺血性坏死患者的血脂和血液流变学影响,中医药临床杂志,2007,19(2):163～164
[15] Yang, H.O., Park, Stimulatory effects of monoacetyldiglycerides on hematopoie -sis, Biol Pharm Bull 27, 2004, 1121-1125.
[16]郇宜俊,骨新生胶囊治疗股骨头坏死的药效学研究,山东中医杂志,2007,26(7):480～482
[17] Yang, H.O., Kim, S.H., Cho,et al, Purification and structural determination of hematopoietic stem cell-stimulating monoacetyldiglycerides from Cervus nippon (deer antler), Chemical and Pharmaceutical Bulletin 52, 2004, 874–878.
[18]张弛,杨志伟,朱明双,等,活血通络法对激素性股骨头坏死家兔模型的组织形态学影响,新疆医科大学学报,2007,30(5):452～454
[19]高彦辉,付松波,孙辉,等,氟中毒大鼠骨组织病理改变动态分析,中国地方病学杂志,2007,26(1):18～21
[20]郇宜俊,骨新生胶囊治疗股骨头坏死的药效学研究,山东中医杂志,2007,26(7):480～482
[21]张弛,何洪阳,杨志伟,等,活血通络法防治激素性股骨头坏死的作用及机制研究,成都中医药大学学报,2007,30(1):39～43
[22]李鸿,贾丙申,激素合并内毒素诱导大鼠股骨头坏死扫描电镜观察,中国比较医学杂志,2007, 17(5):256～258
[23]何齐芳,尚希福,茶黄素抑制激素性股骨头坏死的实验研究,安徽医科大学学报,2007,42(4):415～419
[24]程少容,王仁法,高小玲,等,动态增强MRI评价股骨头血流灌注状态的实验研究,中国临床医学影像杂志,2007,18 (2):110～114
[25]李楠,王和鸣,郭素华,等,巴戟天多糖含药血清对体外培养成骨细胞凋亡的保护作用观察,中国骨伤,2008,21 (1): 39～41
[26]许书亮,洪加源,复元散对激素性股骨头坏死生化代谢影响的实验研究,中国中医骨伤科杂志,1998,6 (6):8～12
[27]金掌,王维佳,王喜波,等,二仙益骨汤对实验性兔股骨头缺血性坏死骨小梁、骨血管面积及矿化等指标的影响,中医正骨,2008,20 (1):3～5
[28] Neuman R.E., Logan M.A., The determination of hydroxyproline. J Biol Chem 184, 1950, 299–306.
[29]熊明月,王坤正,党晓谦,早期激素性股骨头坏死骨细胞凋亡的实验研究,中国修复重建外科杂志,2007,21(3):262～265
[30] Wang Z., Peng H., Li Z.H.,et al, Effect of Cervus and Cucumis Polypeptide Injection on the Rabbits’Radius Fracture and Expression of Vascular Endothelial Growth Factor, Medical Journal of Wuhan University 28, 2007, 193-199.
[31]林永城,曾炎辉,张泽玫,补肾复活汤对中老年股骨头缺血性坏死患者血液流变学的影响,中国康复,2007,22(1):9～10
[32] Meunier P I, Bone histomorphometry in corticosteroid-induced osteo-porosis and cushings syndronce, Advan Exp Med Bio, 1989, 171～191
[33]齐振熙,曹阳,不同治法防治激素性股骨头缺血性坏死的实验研究,中国骨伤,2002,15(2):77～78
[34]章建华,宋登峰,成立,等,骨健制剂对激素性股骨头坏死血液流变学的影响,中医正骨,2008,20(4):13～14
[35]李孝林,杜亚明,张朝驹,等,活骨丸对激素性股骨头缺血坏死家兔血脂及血液流变学的影响,光明中医,2006,21(9):58～59
[36]汪喆，彭昊，李章华，等，鹿瓜多肽注射液对骨折愈合的作用及对血管内皮生长因子表达的影响,武汉大学学报(医学版) ,2007,28(2):196～204
[37]李小宏,李盛华,叶丙霖,激素性股骨头缺血性坏死模型诱导与中药治疗的实验研究进展,甘肃中医,2007,20 (11):58～59
[38]李盛华,姚正凯,激素性股骨头坏死细胞凋亡的实验研究进展,甘肃中医,2007,20(9):61～62
[39]张弛,何洪阳,杨志伟,等,活血通络法防治激素性股骨头坏死的作用及机制研究,成都中医药大学学报,2007,30(1):39～43
[40]闫燃,张雪哲,皮质类固醇致股骨头缺血性坏死的磁共振成像早期改变的实验研究,中日友好医院学报,2007,21(1):28～33
[41]吴云刚,肖鲁伟,童培建,右归饮对激素性股骨头坏死患者股骨近端骨髓骨活性影响的实验研究,中国骨伤,2009,22(2):115～117
[42]何正华,王林,余鹏,不同组织源性细胞作为大动物骨缺损修复研究用骨组织工程种子细胞的增殖及成骨分化比较,武警医学院学报,2008,17 (2) :109～113.
[43]李蔚,孙宜萍,朱国英,雌激素在体外对大鼠成骨细胞的作用,中国组织工程研究与临床康复,2008,12 (11):2061～2064
[44]刘日光,沈冯君,丹仙康骨胶囊对培养成骨细胞影响的观察,中国骨伤,2004,17 (2):77～79
[45]杨亚军,朱庆生,CDMP1诱导大鼠脂肪干细胞体外成软骨细胞的实验研究,第四军医大学学报,2008,29(4):342～345
[46]吴惠明,王维佳,王喜波,等,BMP加丹参治疗股骨头坏死实验研究,中国中医骨伤科杂志,2008, 16 (2):36～39
[47]周小莉,李荣亨,.复元胶囊对软骨细胞凋亡细胞外信号调节蛋白激酶1/2信号通路的作用研究,中国老年学杂志,2008,28(4):329～331
[48]齐振熙,曹阳,不同治法对激素性股骨头坏死生化代谢影响的实验研究,中国中医药信息杂志,2001,8 (12):39～40
[49] Kim S.K, Lee M.H., Rhee, et al, Studies on the effects of biomedicinal agents on serum concentration of Ca2+, P and ALP activity in osteoporosis-induced rats, Journal of Veterinary Science 4, 2003,151–154.
[50]朱文菁,MTT法分析培养成骨细胞的存活和增殖能力,上海医科大学学报,1995,22(4):254～257
[51]中药新药研究指南,北京:中国卫生部药政管理局, 1993,203～207.
[52]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,17～19
[53]赵德伟,田丰德,单纯髋臼前后缘发育不良的解剖学与临床研究,中国临床解剖学杂志,2008,26(1):101～104
[54] Mont M.A,Hungerford D.S,Non-traumatic avascular necrosis of the femoral head,J Bone Joint Surg Am 77, 1995,459-474
[55]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,207
[56]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,235
[57]史永惠,赵熙,左敬全,成人早期股骨头缺血性坏死的影像学诊断价值,实用放射学杂志,2007,23(8):1080～1082
[58]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,169～171
[59]杨党牢,李州利,石炳毅,等,肾移植术后股骨头坏死两例报告并文献复习,现代外科,1999,5(1):46～48
[60]王雨,王爱民,沈岳,等,带旋髂深血管髂骨瓣与人工髋关节置换联合Ⅰ期治疗双侧股骨头无菌性坏死,创伤外科杂志,2007,9(3):222～224
[61]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,134～197
[62]易正湘,龚长虹,成人股骨头缺血坏死的病理及X线、CT、MRI诊断,医学临床研究,2008,25(1):164～166
[63]肖正权,股骨头坏死病学,北京:人民军医出版社,2007,67～85
[64] Vail T.P., Covington D.B., The incidence of osteonecrosis, In: Urbaniak JR, Jones JR, eds. Osteonecrosis: Etiology, Diagnosis, Treatment. Rosemont, Ill: American Academy of Orthopedic Surgeons,1997, 43-49.
[65] Compston, J., Glucocorticoid-induced osteoporosis, Horm Res 60, 2003,77～79
[66]马强,马大庆,靳二虎,等,激素致骨缺血坏死动物模型的影像学初步研究,山西医药杂志,2007,36(4):298～230
[67]胡长根,陈君长,贺西京,等,激素性股骨头坏死与血液流变学变化的关系,西安交通大学学报(医学版) ,2003,24(6):595～598
[68]刘平,刘永平,杜娈英,等,激素性股骨头缺血坏死的发病机理,承德医学院学报,1998,15(3):238～239
[69]程少丹,李武军,杨豪,等,激素性股骨头坏死发病机制研究进展,中医正骨,2002,14(7):51～53
[70]张华峰,马信龙,激素性股骨头坏死的骨质疏松学说,中国骨质疏松杂志,2007,13(2):130～133
[71] Kim K.H., Kim K.S., Choi B.J., et al, Anti-bone resorption activity of deer antler aquaacupunture, Journal of Ethnopharmacology 96, 2005, 497～506
[72] Mok C.C., Lau C.S.,Wong R.W.S., Risk factors for avascular bone necrosis in systemic lupus erythematosus, Br J Rheumatol 37, 1998, 895～900
[73] Mont M.A., Glueck C.J., Pacheco I.H., et al, Risk factors for osteonecrosis in systemic lupus erythematosus, J Rheumatol 24, 1997, 654～662
[74]周正新,袁浩,论治股骨头缺血性坏死的学术特点,中医正骨,2003, 15(6):56～57
[75]林乔龄,李民,儿童股骨头缺血坏死病理机制研究进展,福建中医药, 2000,31(5):41～42
[76]刘艺,张春明,修英霞,等,股骨头坏死患者血液流变学指标的初步观察,微循环学杂志,1997,7(4):27～28
[77]张年春,曾维权,何作云,股骨头坏死的血液流变学临床研究,中国血液流变学杂志,1999,9(4)::227～238
[78]何伟,徐传毅,方斌,等,非创伤性股骨头坏死血液流变学改变及意义,中国中医骨伤科杂志,2001,9(6):24～26
[79]匿名,股骨头坏死的发病原因,求医问药,2004,12:7
[80]崔操,喻爱喜,常巍,等,高压氧对兔激素性股骨头坏死的血液流变学影响,郧阳医学院学报,2006,25(4):214～217
[81]骆生法,激素性股骨头坏死的血液流变学改变,浙江中西医结合杂志,2003,13(8):473～474
[82]崔操,常巍,喻爱喜,高压氧治疗激素性股骨头坏死的血液流变学改变与意义,武汉大学学报(医学版) ,2007,28(1):103～123
[83]俞索静,吴承亮,非创伤性股骨头坏死的病理组织学探讨,中医正骨,2007, 19(8):83～85
[84]赵伦华,朱大和,程少华,高压氧治疗激素诱导兔股骨头缺血性坏死的病理观察,临床与实验病理学杂志,2006,22(1) :78～80
[85]罗杨,刘一,张科强,MAPK信号传导通路在间充质干细胞向成骨细胞分化中的作用,吉林医学,2008,29(6):443～445
[86]宋大勇,赵宝权,刘兴汉,等,重组成骨生长肽对兔同种异体骨移植的成骨影响,哈尔滨医科大学学报,2003,37(6):474～476
[87]唐林,邵玶,林珠,等,不同大小机械牵张力对成骨细胞MMP-13/TIMP-1表达的影响,临床口腔医学杂志,2008, 24 (3):133～136
[88]张永乐,王义生,窦东梅,单纯激素性股骨头坏死发病机制的研究,实用全科医学,2007,5 (8):661～662
[89]崔永锋,肖鲁伟,童培健,硬化带导致股骨头坏死修复过程中断与资源竞争假说,中华中医药学刊,2009,27(1):71～73
[90]秦泗通,蒋青,黄际河,等,p38丝裂原活化蛋白激酶抑制剂对大鼠骨关节炎软骨细胞凋亡的影响,山东医药,,2008, 48 (6):6～8
[91] Kelly P, Montgomery R.J., Bronk J.T. , Reaction of the circulatory system to injury and regeneration, Clin Orthop,1990, 254,275-288.
[92]顾九君,刘兴炎,盛俊东,等,缺氧对大鼠成骨细胞增殖及凋亡的影响,临床军医杂志,2007,35(2):171～173
[93]胡柏松,童培建,激素性股骨头坏死骨重建失衡的实验研究进展,云南中医中药杂志, 2007,28(8):38～40
[94] Mont M.A., Jones L.C., Osteonecrosis of the femoral head Potential treatment with growth and differentiation factors, ClinOthop,1998,314～315
[95]张大学,王丹,生长分化因子治疗股骨头坏死,医学综述,2001,7(9) :517～519
[96]王琪,荀三怀,血管源性生长因子在骨折愈合中的作用,国外医学·骨科学分册,2003,24(4):207～209
[97] Feng J.Q., Chen D., Ghosh-Choudhury, et al, Bone morphogenetic protein 2 transcripts in rapidly developing deer antler tissue contain an extended 5' non-coding region arising from a distal promoter, Biochimica et Biophysica Acta 1350, 1997,47～52
[98]樊粤光,徐传毅,何伟,等,激素性股骨头坏死病程中股骨头局部VEGF mRNA表达的变化及意义,中国矫形外科杂志,2002,10(8):784～786
[99]王正东,柏树令,范军,等, 1,25二羟基胆钙化醇诱导大鼠骨髓单核细胞向破骨细胞转化的机制,解剖学杂志,2008,31(2):148～150
[100]张希中,王清华,王红坡,股骨头缺血坏死的CT早期诊断及分期,新乡医学院学报,2001,18(4):294～295
[101]陈明,郑琼,方真华,阿伦膦酸钠对骨髓生成破骨细胞及骨吸收作用的影响,中国矫形外科杂志, 2008,16 (4):282～284
[102]倪建平,施杞,非创伤性股骨头缺血性坏死的病因研究进展,山东医药,2008,48(6):113～114
[103]郭辉,刘奕琛,葛根素对大鼠成骨细胞代谢调控机制的实验研究,现代中医药,2008,28 (1):48～50
[104] Calder J D, Buttery L,Revell P A,et al, Apoptosis-asignificant cause of bone cell death in osteonecrosis of the femoral head, J Bone JointSurg(Br), 2004, 86(8): 1209-1213.
[105] Eberhardt A W, Yeager-Jones A, Blair H C., Regiona trabecular bone matrix degeneration and osteocyt death in femora of glucocorticoid-treated rabbits, Endocrinology, 2001, 142(3): 1333-1340.
[106] Weinstein R.S., Nicholas R.W., Manolagas S.C., Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip, J Clin Endocrinol Metab, 2000, 85(8): 2907-2912.
[107]齐振熙,陈磊,活血化瘀法对激素性股骨头缺血坏死血液流变学的影响,福建中医学院学报,2006,16 (6):22～24
[108]季爱玉,于腾波,袁万青,等,体内转染Ad/CMV-Htgf-?1对兔椎间盘髓核细胞凋亡及Bcl-2及Bax表达的影响,山东医药,2008,48(17):36～
[109]王建敏,莫耘松,张桂珍,胃黏膜病变组织PNCA、Bcl-2和Bax的表达及意义,实用中西医结合临床,2006,6(5):4～6
[110]刘列,王胜波,赵花,等,颈椎间盘退变过程中细胞凋亡与Bax,Caspase23的表达,第四军医大学学报,2008,29(13):1191～1194
[111]陈德权,邓树勋,彭峰林,间歇运动对大鼠骨骼肌凋亡基因Bax、Bcl-2及相关因素的影响,北京体育大学学报,2008,31(7):922～925
[112]彭程,肖涛,罗远明,等, IGF-1对IL-1诱导的兔关节软骨细胞NO和PGE的影响,中南大学学报(医学版),2008,33(3):197～203
[113]张自强,赵东旭,杨新林,羟脯氨酸的研究与开发,氨基酸和生物资源, 2006,28(1):55～58
[114]吴铁,刘钰瑜,崔燎,等,不同剂量的环磷酰胺对大鼠骨药理作用探讨,中国药理学通报,2001,17(3):329～33
[115] Pedrini Mile A, Chemical study on the ground substance of human epiphy seal plate cartilage, J Bone Joint Surg (Am), 1967 ,49: 1628
[116] Blumenkrantz N.,Asboe-Hansen E., An assay for total hexosamine and a differential assay for glucosamine and galactosamine, Clin Biochem 9, 1976, 269～274
[117]石峰,刘卫东,吉士俊,等,胚胎期及新生儿股骨头骨骺中氨基多糖及钙的含量,中国医科大学学报,1998,27(4):401～403
[118]李刚,通络生骨胶囊治疗激素性股骨头坏死临床与相关实验研究:[博士论文],广州;广州中医药大学,1997
[119]汪喆，彭昊，李章华，等，鹿瓜多肽注射液对骨折愈合的作用及对血管内皮生长因子表达的影响,武汉大学学报(医学版),2007,28(2):196～204
[120]赵玉岩,郭磊,田蕾,等,骨性关节炎软骨细胞中胰岛素样生长因子表达的研究,中国老年学杂志,2009,29(2):195～187
[121]李建华,黄建荣,张雅洁,等,胰岛素样生长因子-1对软骨细胞凋亡的抑制,中国临床康复,2003,23(7):315
[122] Frisbie D D,Sandler E A,Trotter G W, et al. Metablolic and mitogentic activities of insulim-like growth factor-1 in interleukin-1-conditioned equine cartilage,Am J Vet Res,2000,61(4):436～441
[123] Im H J,Pracione C,Chubinskaya S,et al,Inhibitiory effects of insulin-like growth factor-1 angosteogeneic protain-1 on fibronectin fragment-and interleukin -1 beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes,J Biol Chem,2003,278(28):25386-25394
[124] Wang J, Elewaut D, Veys E M, et al,Insulin-like growth factor 1-included interleukin-1 receptorⅡoverrides the activity of interleukin-1 and controls the homecostasis of the extra-cellular matrix of caitilage,Arthritis Rheum,2003, 48(5): 1281-1291.
[125] Makower A M, Skotter A,Wroblewski J,Binding of insulin-like growth factor- 1(TGF-1) to primary cultures of chondrocytes from rats rib growth cartilage,Cell Biol Int Rep,1989,13(5):655-665.
[126]张绍昆,刘一,吴宏,等,外源性人胰岛素样生长因子-1基因在关节软骨细胞中的表达,中华实验外科杂志,2005,3(22):278～280
[127] Hyun H.J.,Chan H.K., Jong H. C.,et al, Bilateral anterior cingulotomy for refractory obsessive-compulsive disorder:Long-term follow-up results, Chin J Nerv Ment Dis, 2006, 32 (5):392-398.
[128]文良元,黄公怡,路奎元,等,激素型股骨头坏死的发病机制研究,中华外科杂志,1998,36 (1):39～41
[129]郭磊,赵玉岩,张世亮,等,维甲酸调控IGF-2基因对软骨细胞促凋亡的作用,中国修复重建外科杂志,2008,22 (2):217～220
[130]郭磊,赵彦艳,董凌月,等,二恶英对成骨细胞胰岛素样生长因子家族基因表达的抗雌激素作用,中华医学遗传学杂志, 2003, 20(6):490～494
[131] Chang C C, Osteo-necrosis current perr-spectives on pathogenesis and treatment, Semin Arthritis- Rheum,1993,23(1):47
[132]赵金东,吕松岑,薛震,等,激素性股骨头坏死动物模型的建立与评价,中国骨肿瘤骨病,2007,6(4):220～225
[133]宋渊,李盛华,股骨头缺血性坏死动物模型研究进展,甘肃中医,2006, 19(5):43～45
[134]田琨,童培建,肖鲁伟,激素性股骨头缺血性坏死动物模型研究进展,江西中医学院学报,2007,19(1):95～97
[135]周强,李起鸿,柳风轩,持续大剂量地塞米松诱导兔股骨头坏死的实验研究,西藏医药杂志,1999,20(3):19
[136]Yamat nat oT, Corticosteroid enhances the exprimental in-duction of osteonecerosis on rabbits with shwartzman reaction, Clin Orthop,1995,316.
[137] Mastuim saito S,Ohzono K, Experimental steroid in duced ostenecrosis inadult rabbits withhypersensitivity was colitis, Clin Orthop, 1992, 61.
[138]周景华,王立春,活骨汤治疗股骨头缺血性坏死的实验研究,中医研究,2000,16(1):45
[139]郭坤亮,安洪,蒋电明,酒精性股骨头缺血性坏死动物模型的建立与探讨,贵州医药,2002,26(10):882～884
[140]杨述华,杨操,许伟华,等,液氮冷冻建立兔股骨头缺血性坏死模型,中华矫形外科杂志,2001,8(1):48
[141]王江泳,王保芝,崔慧先,改良液氮冷冻法制备家兔股骨头坏死模型的形态学研究,河北医科大学学报,2008, 29(1):5～8
[142]王胜军,赵文海,液氮冷冻建立兔股骨头缺血性坏死模型,长春中医药大学学报,2008,24(4):402～403
[143]陈凯,蔡郑东,多孔担金属植人治疗早期股骨头坏死研究进展,国际骨科学杂志,2008, 29(1):41～42
[144]黄昌林,高旺,黄涛,中药对非创伤性股骨头坏死分期治疗作用的临床观察,解放军医学杂志,2009, 34(5):504～505